Zypsilan 80 mg Slovakia - slovakisk - ŠÚKL (Štátny ústav pre kontrolu liečiv)

zypsilan 80 mg

krka, d.d., novo mesto, slovinsko - ziprazidón - 68 - antipsychotica (neuroleptica)

Asolfena 5 mg Slovakia - slovakisk - ŠÚKL (Štátny ústav pre kontrolu liečiv)

asolfena 5 mg

krka, d.d., novo mesto, slovinsko - solifenacín - 73 - spasmolytica

Asolfena 10 mg Slovakia - slovakisk - ŠÚKL (Štátny ústav pre kontrolu liečiv)

asolfena 10 mg

krka, d.d., novo mesto, slovinsko - solifenacín - 73 - spasmolytica

Rosuvastatin Mylan 5 mg Slovakia - slovakisk - ŠÚKL (Štátny ústav pre kontrolu liečiv)

rosuvastatin mylan 5 mg

mylan ireland limited, Írsko - rosuvastatín - 31 - hypolipidaemica

Rosuvastatin Mylan 10 mg Slovakia - slovakisk - ŠÚKL (Štátny ústav pre kontrolu liečiv)

rosuvastatin mylan 10 mg

mylan ireland limited, Írsko - rosuvastatín - 31 - hypolipidaemica

Rosuvastatin Mylan 20 mg Slovakia - slovakisk - ŠÚKL (Štátny ústav pre kontrolu liečiv)

rosuvastatin mylan 20 mg

mylan ireland limited, Írsko - rosuvastatín - 31 - hypolipidaemica

Rosuvastatin Mylan 40 mg Slovakia - slovakisk - ŠÚKL (Štátny ústav pre kontrolu liečiv)

rosuvastatin mylan 40 mg

mylan ireland limited, Írsko - rosuvastatín - 31 - hypolipidaemica

Vaxneuvance Den europeiske union - slovakisk - EMA (European Medicines Agency)

vaxneuvance

merck sharp & dohme b.v.  - pneumococcal polysaccharide conjugate vaccine (adsorbed) - pneumokokové infekcie - pneumococcus, purified polysaccharides antigen conjugated - vaxneuvance is indicated for active immunisation for the prevention of invasive disease, pneumonia and acute otitis media caused by streptococcus pneumoniae in infants, children and adolescents from 6 weeks to less than 18 years of age. vaxneuvance is indicated for active immunisation for the prevention of invasive disease and pneumonia caused by streptococcus pneumoniae in individuals 18 years of age and older. pozri časti 4. 4 a 5. 1 pre informácie o ochrane proti špecifickým pneumokokovým sérotypom. the use of vaxneuvance should be in accordance with official recommendations.

Ontilyv Den europeiske union - slovakisk - EMA (European Medicines Agency)

ontilyv

bial portela & companhia s.a. - opicapone - parkinsonova choroba - antiparkinsonické lieky - ontilyv is indicated as adjunctive therapy to preparations of levodopa/ dopa decarboxylase inhibitors (ddci) in adult patients with parkinson’s disease and end-of-dose motor fluctuations who cannot be stabilised on those combinations.